Immunovia AB: A Focus on Cancer Diagnosis and Monitoring

Immunovia AB, a company based in Lund, Sweden, operates within the health care sector, specifically in the health care equipment and supplies industry. The company is listed on the Swedish Stock Exchange and trades in SEK. As of August 17, 2025, Immunovia’s close price was recorded at 0.575 SEK, with a market capitalization of 175,997,781 SEK.

Specialization in Bioinformatic Devices

Immunovia AB specializes in the development and manufacturing of bioinformatic devices. These devices are designed to aid in the diagnosis of cancer, predict disease progression, and monitor the therapeutic responsiveness of cancers. The company’s focus on bioinformatics positions it as a key player in the health care sector, particularly in oncology.

Market Presence and Clientele

Immunovia serves its clients exclusively within Sweden, maintaining a strong domestic presence. The company’s commitment to serving the Swedish market is reflected in its operations and client interactions.

Financial Overview

Over the past year, Immunovia’s stock has experienced fluctuations. The 52-week high was reached on September 17, 2024, at 1.31 SEK, while the 52-week low was recorded on April 6, 2025, at 0.244 SEK. These figures highlight the volatility in the company’s stock performance over the past year.

Conclusion

Immunovia AB continues to focus on its core mission of providing advanced bioinformatic solutions for cancer diagnosis and monitoring. With its operations centered in Sweden, the company remains a significant contributor to the health care equipment and supplies sector.